Conserved CDR 3 region of T cell receptor BV gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis

Clinical and Experimental Immunology

Volumn 129, Issue 1, 2002, Pages 140-149

  Shimizudani, N ^a,b   Murata, H ^a   Keino, H ^a   Kojo, S ^a   Nakamura, H ^b   Morishima, Y ^a   Sakamoto, T ^a   Ohtsuka, M ^a   Sekisawa, K ^a   Sumida, M ^c   Sumida, T ^a   Matsuoka, T ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Clonality; IPF; Pathogenesis; T cell receptor; T lymphocytes

Indexed keywords

T LYMPHOCYTE RECEPTOR;

AGED; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLONAL VARIATION; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; LUNG FIBROSIS; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MOTIF; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BRONCHOALVEOLAR LAVAGE FLUID; CLONE CELLS; COMPLEMENTARITY DETERMINING REGIONS; DNA, COMPLEMENTARY; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PULMONARY FIBROSIS; T-LYMPHOCYTE SUBSETS;

EID: 0036378125     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01871.x     Document Type: Article

References (30)

1. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310:235-44.
2. Crystal RG, Gedek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghaku GW. Interstitial lung disease, current concepts of pathogenesis, staging, and therapy. Am J Med 1981; 70:542-68.
3. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationship of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981; 124:1-8.
4. Haslam PL, Turton CW, Lukoszik A et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and relation to therapy. Thorax 1980; 35:328-39.
5. Haslam PL, Turton CW, Heard B et al. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax 1980; 35:9-18.
6. Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance and pathologic classification. Am J Respir Crit Care Med 1998; 157:130-15.
7. Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157:199-203.
8. Ryu JH, Colby TV, Hartmann TE. Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc 1998; 11:1085-101.
9. Paliard X, West SG, Lafferty JA et al. Evidence for the effects of a super antigen in rheumatoid arthritis. Science 1991; 253:325-8.
10. Sumida T, Sakamaki T, Yonaha F et al. HLA-DR alleles in patients with Sjögren's syndrome over-representing Sjögren's syndrome Vb2 and Vb13 genes in the labial salivary glands. Br J Rheumatol 1994; 33:42014.
11. Sumida T, Yonaha F, Maeda T et al. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J Clin Invest 1992; 89:681-5.
12. Kotzin BL, Karuturi S, Chou YK et al. Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 1991; 88:9161-5.
13. Wucherpfening KW, Ota K, Endo N et al. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. Science 1990; 248:1016-9.
14. Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG. Bias toward use of specific T cell receptor beta-chain variable region in a subgroup of individuals with sarcoidosis. J Clin Invest 1988; 82:1183-91.
15. Zissel G, Baumer I, Fleischer B, Schlaak M, Muller-Quernheim J. TCR V beta families in T cell clones from sarcoid lung parenchyma, BAL, and blood. Am J Respir Crit Care Med 1997; 156:1593-600.
16. Bellocq A, Lecossier D, Pierre-Audigier C, Tazi A, Valeyre D, Hance AJ. T cell receptor repertoire of T lymphocytes recovered from the lung and blood of patients with sarcoidosis. Am J Respir Crit Care Med 1994; 149:646-54.
17. Hodges E, Dasmahapatra J, Smith JL et al. T cell receptor Vβ gene usage in bronchoalveolar lavage and peripheral blood T cells from asthmatic and normal subjects. Clin Exp Immunol 1998; 112:363-74.
18. Umibe T, Kita Y, Nakao A et al. Clonal expansion of T cells infiltrating in the airways of non-atopic asthmatics. Clin Exp Immunol 2000; 119:390-7.
19. Yamamoto K, Sakoda H, Nakajima T et al. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol 1992; 4:1219-23.
20. Jones CM, Lake RA, Wijeyekoon JB, Mitchell DM, du Bois RM, O'Hehir RE. Oligoclonal V gene usage by T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients. Am J Cell Mol Biol 1996; 14:470-7.
21. Vissinga C, Springmeyer SC, Concannon P. TCR expression and clonality analysis in pulmonary sarcoidosis. Hum Immunol 1996; 48:98-106.
22. Lympany PA, Southcott AM, Welsh KI, Boylston AW, du Bois RM. T-cell receptor gene usage in patients with fibrosing alveolitis and control subjects. Eur J Clin Invest 1999; 29:173-81.
23. Gruber R, Pforte A, Beer B, Riethmuller G. Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idiopathic fibrosis of the lung. APMIS 1995; 104:199-203.
24. Ueda T, Ohta K, Suzuki N et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992; 146:266-8.
25. Kuwano K, Nomoto Y, Kunitake R et al. Detection of adenovirus EIA DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J 1997; 10:1445-9.
26. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carrol KB, Woodcock AA. Epstein-Barr virus replication within pulmonary epithelial cells, in cryptogenic fibrosing alveolitis. Thorax 1995; 50:1234-9.
27. Yonemaru M, Kasuga H, Kusumoto H et al. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur Respir J 1997; 10:2040-5.
28. Vergnon JM, Vincent M, de The G, Mornex JF, Weynants P, Brune J. Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association. Lancet 1984; ii:768-71.
29. Wangoo A, Shaw RJ, Diss TC, Farrell PJ, du Bois RM, Nicholson AG. Cryptogenic fibrosing alveolitis. Lack of association with Epstein-Barr virus infection. Thorax 1997; 52:888-91.
30. Jiwa M, Steenbergen RD, Zwaan FE, Kluin PM, Raap AK, Ploeg M. Three sensitive methods for the detection of cytomegalovirus in lung tissue of patients with interstitial pneumonia. Am J Clin Pathol 1990; 93:491-4.